STAT+: Pharmalittle: We’re reading about payments to Russian middlemen, a possible Dupixent rival, and more
Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government entities
Reported by STAT. We will add other newspapers as they cover it.
How the newspaper covers this story
STAT+: Pharmalittle: We’re reading about payments to Russian middlemen, a possible Dupixent rival, and more
Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government entities
